BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 25714613)

  • 21. Transforming growth factor-beta 1 enhances the generation of allospecific cytotoxic T lymphocytes.
    Kondo S; Isobe K; Ishiguro N; Nakashima I; Miura T
    Immunology; 1993 Jul; 79(3):459-64. PubMed ID: 8406573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship of TGF-β1 and Smad7 expression with decreased dendritic cell infiltration in liver gastrointestinal cancer metastasis.
    Gulubova M; Manolova I; Ananiev J; Kjurkchiev D; Julianov A; Altunkova I
    APMIS; 2013 Oct; 121(10):967-75. PubMed ID: 23998914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TGF-beta as a promising option in the treatment of multiple sclerosis.
    Mirshafiey A; Mohsenzadegan M
    Neuropharmacology; 2009; 56(6-7):929-36. PubMed ID: 19285095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Innate and adaptive immune pathways to tolerance.
    Thornton CA; Morgan G
    Nestle Nutr Workshop Ser Pediatr Program; 2009; 64():45-57; discussion 57-61, 251-7. PubMed ID: 19710514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathobiology of transforming growth factor beta in cancer, fibrosis and immunologic disease, and therapeutic considerations.
    Prud'homme GJ
    Lab Invest; 2007 Nov; 87(11):1077-91. PubMed ID: 17724448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The liver and the immune system].
    Jakab L
    Orv Hetil; 2015 Jul; 156(30):1203-13. PubMed ID: 26186144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppressive effects of androgens on the immune system.
    Trigunaite A; Dimo J; Jørgensen TN
    Cell Immunol; 2015 Apr; 294(2):87-94. PubMed ID: 25708485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transforming growth factor beta inhibits the antigen-presenting functions and antitumor activity of dendritic cell vaccines.
    Kobie JJ; Wu RS; Kurt RA; Lou S; Adelman MK; Whitesell LJ; Ramanathapuram LV; Arteaga CL; Akporiaye ET
    Cancer Res; 2003 Apr; 63(8):1860-4. PubMed ID: 12702574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Foxp3-transduced polyclonal regulatory T cells suppress NK cell functions in a TGF-beta dependent manner.
    Zhou H; Chen L; You Y; Zou L; Zou P
    Autoimmunity; 2010 Jun; 43(4):299-307. PubMed ID: 20166879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Revisiting the regulatory roles of the TGF-β family of cytokines.
    Fujio K; Komai T; Inoue M; Morita K; Okamura T; Yamamoto K
    Autoimmun Rev; 2016 Sep; 15(9):917-22. PubMed ID: 27392504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activated human CD4+ T cells induced by dendritic cell stimulation are most sensitive to transforming growth factor-beta: implications for dendritic cell immunization against cancer.
    Lin CM; Wang FH; Lee PK
    Clin Immunol; 2002 Jan; 102(1):96-105. PubMed ID: 11781072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression.
    Yang L; Pang Y; Moses HL
    Trends Immunol; 2010 Jun; 31(6):220-7. PubMed ID: 20538542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transforming growth factor-beta: an important role in CD4+CD25+ regulatory T cells and immune tolerance.
    Zhang L; Yi H; Xia XP; Zhao Y
    Autoimmunity; 2006 Jun; 39(4):269-76. PubMed ID: 16891215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exposure of anionic phospholipids serves as anti-inflammatory and immunosuppressive signal--implications for antiphospholipid syndrome and systemic lupus erythematosus.
    Gaipl US; Beyer TD; Baumann I; Voll RE; Stach CM; Heyder P; Kalden JR; Manfredi A; Herrmann M
    Immunobiology; 2003; 207(1):73-81. PubMed ID: 12638907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A role for TGF-beta in the suppression by murine bronchoalveolar cells of lung dendritic cell initiated immune responses.
    Lipscomb MF; Pollard AM; Yates JL
    Reg Immunol; 1993; 5(3-4):151-7. PubMed ID: 8240933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of intracellular transforming growth factor-beta1 in CD4+CD25+ cells in patients with systemic lupus erythematosus.
    Lu LY; Chu JJ; Lu PJ; Sung PK; Hsu CM; Tseng JC
    J Microbiol Immunol Infect; 2008 Apr; 41(2):165-73. PubMed ID: 18473105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation and role of transforming growth factor-beta in immune tolerance induction and inflammation.
    Schmidt-Weber CB; Blaser K
    Curr Opin Immunol; 2004 Dec; 16(6):709-16. PubMed ID: 15511662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of messenger RNA for transforming growth factor-beta1 and for transforming growth factor-beta receptors in peripheral blood of systemic lupus erythematosus patients treated with low doses of quinagolide.
    Hrycek A; Kusmierz D; Dybała T; Swiatkowska L
    Autoimmunity; 2007 Feb; 40(1):23-30. PubMed ID: 17364494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TGF-β favors bone marrow-derived dendritic cells to acquire tolerogenic properties.
    Song SS; Yuan PF; Chen JY; Fu JJ; Wu HX; Lu JT; Wei W
    Immunol Invest; 2014; 43(4):360-9. PubMed ID: 24484319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TGF-beta and kynurenines as the key to infectious tolerance.
    Belladonna ML; Orabona C; Grohmann U; Puccetti P
    Trends Mol Med; 2009 Feb; 15(2):41-9. PubMed ID: 19162548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.